FDA scaling back API facility inspections in US; Socma asks FDA to ensure frequency of inspections does not exceed three years
10:27 AM | May 30, 2014 | Deepti Ramesh
The Bulk Pharmaceuticals Task Force (BPTF), an affiliate of Socma, issued a letter on 27 May to the US Food and Drug Administration (FDA) asking that the agency ensure the frequency of inspections for...
This information is only available to subscribers.
chemweek.com is the one stop platform for chemical news, data and analysis across all industry sectors and geographies.